Partnership includes finding new applications and improving instrumentation.

Bruker Daltonics established a long-term collaboration with the University of Warwick to develop both applications and fundamental instrument technology in extreme-resolution mass spectrometry.

Technology development will be headed by Warwick professor Peter O’Connor, Ph.D. “We are very excited to be able to benefit from Peter’s ideas, and have arranged a technical fast-track for his developments to appear in our FTMS products,” comments Michael Schubert, Ph.D., evp for R&D at Bruker.

The partnership will also research metals in biology and medicine. “In my field state-of-the-art analysis of metal speciation holds the key to major breakthroughs in understanding both how metal ions control natural biological processes and how metal complexes can be designed as novel therapeutic agents,” points out Peter Sadler, D.Phil., head of chemistry at the University. His research interests focus on metals in biology and medicine, the design and mechanism of action of metallodrugs, and the role of proteins in metal-induced signal transduction.

The University of Warwick recently installed the new Bruker solariX™ 12 Tesla FTMS system and the maXis™ UHR-TOF system. At the core of the new instruments are dramatic improvements, up to an order of magnitude, in previous performance standards.

Previous articleBioWa Grants Merck KGaA Access to Technology that Enhances Antibody-Dependent Cellular Cytotoxicity
Next articleAlnylam and Novartis Take RNAi Therapeutics Collaboration into Fifth Year